Journals / Psychiatry and behavioral sciences (Online) / 2020 / Cilt: 10 - Sayı: 1

Decreased Levels of Fasting Serum Leptin in Patients With Schizophrenia: A Case-Control Study

Pages
1–6
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Future studies are considered the role of adipose tissue related pathways and gender differences to understand the underlying mechanisms of metabolic disruptions in patients with schizophrenia.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Evidence suggested that leptin may be implicated in the pathophysiology of metabolic disruptions in schizophrenia.
📊
Key Findings & Data:Methods: Forty-eight patients with schizophrenia and 36 age-gender-BMI matched healthy controls (HC) were assessed.
💡
Conclusion & Impact:Future studies are considered the role of adipose tissue related pathways and gender differences to understand the underlying mechanisms of metabolic disruptions in patients with schizophrenia.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: Evidence suggested that leptin may be implicated in the pathophysiology of metabolic disruptions in schizophrenia. The findings of the leptin in patients with schizophrenia have been inconsistent. The aim of this study was to evaluate fasting leptin in the patients with schizophrenia and the association with leptin levels and gender, BMI, clinical variables such as psychopathology scores, suicidal behaviour and type of medication. Methods: Forty-eight patients with schizophrenia and 36 age-gender-BMI matched healthy controls (HC) were assessed. We collected venous blood samples in the morning and serum leptin were measured using the ELISA kit. Results: The levels of fasting leptin were significantly decreased in patients with schizophrenia compared with the HC (P=0.021), also after adjusting for confounders (P=0.009). In the regression analysis, being female (β=−0.51, t=-3.458, P<0.001) and higher BMI (β=3.675, t=3.675, P<0.001) were found significant predictor to higher level of the fasting leptin and we did not observe a relationship between fasting level of leptin and age, smoke status, cumulative antipsychotic use, clinical status and having suicidal attempt in patients with schizophrenia. Conclusion: The exploratory study detected decreased fasting leptin levels and significant relationships between higher leptin levels and gender and BMI in the stable medicated patients with schizophrenia. Future studies are considered the role of adipose tissue related pathways and gender differences to understand the underlying mechanisms of metabolic disruptions in patients with schizophrenia.

🔖

Cite This Article

ŞAHBAZ, Ç. D., ÖZER, Ö. F., KURTULMUŞ, A., KIRPINAR, I., GÜLÖKSÜZ, S. (2020). Decreased Levels of Fasting Serum Leptin in Patients With Schizophrenia: A Case-Control Study. Psychiatry and behavioral sciences (Online), Cilt: 10 - Sayı: 1, 1–6. https://ajindex.com/articles/302784

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. McEvoy JP, Meyer JM, Goff DC, Nasrallah HA, Davis SM, Sullivan L, et al. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophrenia Research. 2005;80(1):19-32
  2. Mitchell AJ, Vancampfort D, De Herdt A, Yu W, De Hert M. Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients. Schizophrenia Bulletin. 2013;39(2):295-305
  3. Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. American Heart Journal. 2005;150(6):1115-21
  4. Robillard R, Rogers NL, Whitwell BG, Lambert T. Are cardiometabolic and endocrine abnormalities linked to sleep difficulties in schizophrenia? A hypothesis driven review. Clinical psychopharmacology and neuroscience: The Official Scientific Journal of the Korean College of Neuropsychopharmacology. 2012;10(1):1-12
  5. Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry. 2015;72(4):334-41
  6. Hjorthoj C, Sturup AE, McGrath JJ, Nordentoft M. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. The Lancet Psychiatry. 2017;4(4):295-301
  7. Stubbs B, Wang AK, Vancampfort D, Miller BJ. Are leptin levels increased among people with schizophrenia versus controls? A systematic review and comparative metaanalysis. Psychoneuroendocrinology. 2016;63:144-54
  8. Sahu A. Leptin signaling in the hypothalamus: emphasis on energy homeostasis and leptin resistance. Frontiers in Neuroendocrinology. 2003;24(4):225-53
  9. Zhou Y, Rui L. Leptin signaling and leptin resistance. Frontiers of Medicine. 2013;7(2):207-22
  10. Koh KK, Park SM, Quon MJ. Leptin and cardiovascular disease: response to therapeutic interventions. Circulation. 2008;117(25):3238-49
  11. Pfaffly J, Michaelides M, Wang GJ, Pessin JE, Volkow ND, Thanos PK. Leptin increases striatal dopamine D2 receptor binding in leptin-deficient obese (ob/ob) mice. Synapse (New York, NY). 2010;64(7):503-10
  12. Hommel JD, Trinko R, Sears RM, Georgescu D, Liu ZW, Gao XB, et al. Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron. 2006;51(6):801-10.